PDS Biotechnology Corp - Common (PDSB)

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Common
Shares outstanding
49,594,356
Number of holders
19
Total 13F shares, excl. options
1,628,998
Shares change
+1,089,294
Total reported value, excl. options
$1,184,000
Value change
+$761,576
Number of buys
10
Number of sells
-4
Price
$0.7250

Significant Holders of PDS Biotechnology Corp - Common (PDSB) as of Q1 2020

21 filings reported holding PDSB - PDS Biotechnology Corp - Common as of Q1 2020.
PDS Biotechnology Corp - Common (PDSB) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,628,998 shares of 49,594,356 outstanding shares and own 3.3% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (384,000 shares), RENAISSANCE TECHNOLOGIES LLC (309,621 shares), Worth Venture Partners, LLC (162,000 shares), FIRST MANHATTAN CO (149,067 shares), Sofinnova Investments, Inc. (142,635 shares), New Leaf Venture Partners, L.L.C. (117,242 shares), Hudson Bay Capital Management LP (75,342 shares), MILLENNIUM MANAGEMENT LLC (67,235 shares), UBS Group AG (38,400 shares), and Bank of New York Mellon Corp (36,364 shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.